Literature DB >> 1110307

Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity.

J P Atkinson, R H Glew, F A Neva, M M Frank.   

Abstract

The role of complement in the control of parasitemia was examined. Depletion of late components (3-9) by cobra venom factor did not alter either the degree or course of parasitemia during the pre-immune or immune stages of infection. The pattern of consumption of complement components was therefore examined. Concomitant with schizont rupture there was depletion of early-acting components (C1, C4, and C2) of the clasical complement pathway. The magnitude and remporal relationships of the fall were similar for these three components. Serum levels returned to prerupture values over 36-48 hr, and then the cycle was repeated. There was no simultaneous change in the levels of C3, C3 proactivator, or C6. These results delineate a new pattern of cyclical consumption of early components of the classical complement pathway associated temporally with schizont rupture and suggest that the late-acting components are not required for protective host immunity in malaria.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110307     DOI: 10.1093/infdis/131.1.26

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Host immune responses to experimental infection of Plasmodium relictum (lineage SGS1) in domestic canaries (Serinus canaria).

Authors:  Vincenzo A Ellis; Stéphane Cornet; Loren Merrill; Melanie R Kunkel; Toshi Tsunekage; Robert E Ricklefs
Journal:  Parasitol Res       Date:  2015-07-07       Impact factor: 2.289

2.  Serum inhibition of merozoite dispersal from Plasmodium falciparum schizonts: indicator of immune status.

Authors:  T J Green; M Morhardt; R G Brackett; R L Jacobs
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

3.  Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria.

Authors:  C Adam; M Géniteau; M Gougerot-Pocidalo; P Verroust; J Lebras; C Gibert; L Morel-Maroger
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Recent advances in applied malaria immunology.

Authors:  C A Speer; P H Silverman
Journal:  Z Parasitenkd       Date:  1979-11

5.  Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

7.  Complement in experimental Trypanosoma lewisi infection of rats.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  The role of complement in Ascaris suum induced histopathology.

Authors:  R Leventhal; H Bonner; E J Soulsby; A D Schreiber
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

9.  Complement does not play a role in promoting Babesia rodhaini infections in Balb/C mice.

Authors:  W Seinen; T Stegmann; H Kuil
Journal:  Z Parasitenkd       Date:  1982

10.  Humoral immunostimulation. IV. Role of complement.

Authors:  W T Shearer; J P Atkinson; M M Frank; C W Parker
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.